Search
Mesoblast Ltd
MESOAdd to Watchlist
14.170USD
-0.380-2.61%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.87BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Mesoblast Ltd is 8.00, ranking 171 out of 385 in the Biotechnology & Medical Research industry. The average price target is 35.00, with a high of 35.00 and a low of 35.00.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
34.667
Target Price
+144.65%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Mesoblast Ltd
MESO
3
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Mesoblast Ltd's price target?
Analysts forecast that Mesoblast Ltd's price target is USD 35.00, with the highest forecast at USD 35.00 and the lowest forecast at USD 35.00.
What is the analyst rating for Mesoblast Ltd?
Based on the ratings of Mesoblast Ltd's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.